In parallel, the Signal Transducer and Activator of Transcription 3 (STAT3) is constitutively activated in approximately 60% of HCC cases, promoting cell proliferation, angiogenesis, and immune evasion through the transcriptional activation of genes like Cyclin D and VEGF [23,24]. Here, STAT3 is linked to hepatocellular carcinoma.